CVS Health steps into the biosimilar arena with a new subsidiary, bringing Sandoz’s Humira biosimilar to market

CVS Health announced Wednesday that it launched a business that will work with drugmakers to commercialize and manufacture biosimilars in the US, starting with a Humira biosimilar developed by Sandoz.

Sandoz has said it plans to launch Hyrimoz in September, and now the biosimilar will…
Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks